Patent · US Active

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

US12128021B1 · kind B1 · utility

9Cited by

268References

26Claims

0Family size

Assignee

Flamel Ireland Limited · IE

Inventors

Claire Mégret · L'Essart Mador, FR
Hervé Guillard · Villeurbanne, FR
Jean-François Dubuisson · L'Essart Mador, FR

Key dates

Filing date	Apr 23, 2024
Grant date	Oct 29, 2024
Priority date	—
Expiry date	Apr 23, 2044

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/19
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.